[China Pharmaceutical Network Pharmaceutical Engineering] The Qujing Biopharmaceutical Industrial Park project has taken a solid step forward. According to reports, the Qujing Biopharmaceutical Industrial Park Project is another important measure for deepening the cooperation between the ITRI Group and Qujing City. The project is expected to invest 3 billion yuan, and will focus on the construction of plasmapheresis stations, blood product bases, and monoclonal antibody production bases.

On the afternoon of September 19th, the signing ceremony of the Qujing Biopharmaceutical Industrial Park project was held in Qujing Economic Development Zone, which marked a solid step forward in the development of Qujing's biopharmaceutical industry.

Dong Baotong, deputy secretary of the Qujing municipal committee and mayor of the city, said at the signing ceremony that the Provincial Industrial Investment Group is an important leading enterprise in the province's industrial transformation and development. The signing of the Qujing Bio-pharmaceutical Industrial Park project is one of deepening the development of Qujing's bio-pharmaceutical industry. As an important opportunity, the project meets the requirements and direction of industrial transformation and upgrading of provinces and cities. The project will settle in Qujing Economic Development Zone and will play an important supporting role in the development of Qujing and the development of Qujing Economic Development Zone. The relevant departments of the Qujing Economic Development Zone and the Municipality shall fully provide services and build first-class projects through first-class services so that the projects can be completed and reached production as soon as possible to achieve the expected development goals. At the same time, products, benefits, modes, and talents will be produced. The city’s economic and social development has made important contributions.

Liu Yiwen, chairman of Yunnan Industrial Investment Group, said at the signing ceremony that the Qujing Biopharmaceutical Industrial Park project is another important measure for deepening cooperation between the ITRI Group and Qujing City. The project is expected to invest 3 billion yuan, and will focus on building plasmapheresis stations. , blood product bases and monoclonal antibody production bases. After the project has reached full production, it is expected that the annual output value will reach 2 billion yuan, profits and taxes 600 million yuan, and 300 new jobs will be created. Industrial Investment Group will use the park as a carrier to focus on the development of the pharmaceutical industry and help Yunnan achieve leapfrog development.

At the signing ceremony, the municipal government signed the "Qujing Biopharmaceutical Industrial Park Strategic Cooperation Agreement" with Yunnan Industrial Investment Group and Yunnan Wokang Biotechnology Co., Ltd., Qujing Economic Development Zone Management Committee and Yunnan Industrial Investment Group, Yunnan Wokang Biotechnology Co., Ltd. Co., Ltd. signed the "Qujing Biopharmaceutical Industrial Park project investment agreement"; Yunnan Watson Biotechnology Co., Ltd. President Jiang Runsheng, Qujing Jingkai District Administrative Committee Director Yu Jie made a statement.

Qujing Municipal Party Standing Committee and deputy mayor Wang Zhuo presided over the signing ceremony. Sun Degang, President of Yunnan Industrial Investment Group, Fu Xuebin, Member of the Standing Committee of the Municipal Party Committee, Deputy Mayor of the Municipal Party Committee, Zhang Changying, Member of the Standing Committee of the Municipal Party Committee and Minister of the United Front Work Department of the Municipal Party Committee, Chen Jishu, Vice Chairman of the Municipal People's Political Consultative Conference, Zhong Yu, Secretary General of the Municipal Government, Yunnan Industrial Investment Group, Yunnan Watson Biotechnology Co., Ltd. Relevant leaders of the company, relevant municipal departments, Qujing Economic Development Zone, and relevant county (district) leaders attended the signing ceremony.